AutomaPlus 2026: Pharma Automation & Digitalisation Congress

We are proud to announce that for the 6th edition of AutomaPlus in 2026, we will be partnering with GSK, Boehringer Ingelheim Pharma GmbH & Co.KG, Bachem AG and Novartis. As leading innovators in the pharmaceutical industry, these companies are driving digital transformation and setting new standards in operational excellence. Their support plays an important role in making AutomaPlus a truly global platform for sharing ideas, best practices, and the latest advancements in pharma manufacturing and automation. We are grateful for their partnership and look forward to an inspiring and impactful congress together.

We offer different formats of participation to support your digital strategies and objectives in the pharmaceutical industry. These tailored formats provide you with the flexibility to choose the most suitable option that aligns with your current business aims and helps you make the most of your participation in our event.

The Congress will focus on innovative industry-led content: digitalisation & automation trends, challenging topics, and newest technologies. AutomaPlus business programme attracts digital experts from pharma majors, local pharma companies, contract manufacturing & research companies, APIs, associations together with pharmaceutical equipment providers and service companies whose case studies cover the ongoing, existing and planned projects devoted to the digital pharma ecosystem.

Leveraging digital technologies for safety, automation, and anti-counterfeiting in pharma logistics

Social Media & Digital Content Channels for Pharma and Patient-Centricity Through Digital

To make participation in the AutomaPlus Pharmaceutical edition successful you should define your business goals and choose the most appropriate format. Tell us more about your projects and current business priority in pharmaceutical automation and digitalisation, and we will find you the perfect match!